One of the biggest claims related to stem cells and in particular to induced pluripotent stem cells (IPSC or IPS cells) of 2015 came just yesterday about growing a human fetal brain. A press release from Ohio State University reports that two of its researchers had grown a nearly full-formed human fetal brain. My initial reaction […]
Healthy skepticism needed on claim of stem cell-derived human fetal brain Read More »
Masayo Takahashi (高橋 政代) on IPSC Trial for Macular Degeneration By Michael Cea Stem Cell Analyst & Advocate (editor’s note: piece was originally posted on Michael’s blog here; follow Michael on Twitter @msemporda) Masayo Takahashi interview Having followed closely the developments in programs using pluripotent based therapeutics I was fortunate during ISSCR2015 to have the opportunity to
Masayo Takahashi (高橋 政代) on IPSC Trial for Vision Read More »
Stemedica announced it is teaming up with UC San Diego (UCSD) to do stem cell research. This fits with an increasing trend in the stem cell arena is the teaming up of clinical partners with very different backgrounds and priorities. For instance, academic institutions are more often working together with for-profit stem cell clinics. Another branch
Muddier stem cell waters: Stemedica teams up with UCSD doc? Read More »
Popular Science recently did a piece on stem cell clinics that has raised some red flags. The concerns in this case are not necessarily about the clinics per se, but rather the actual article itself. There are a lot of stem cell clinics out there and for years they had a pretty consistent strategy of
Popular Science stem cell clinic article itself raising some red flags Read More »
Many of us scientists, ethicists, and legal scholars are working on educational outreach to the public on the potential use of gene editing technologies like CRISPR to genetically modify human beings, but clearly there’s a long way to go and much more to do on this front. By the way, you may find this new
Public polling on human gene editing, moratorium Read More »
What is the “proper” amount of freedom of choice for patients in medicine? What if the treatments in question are experimental and come with their own baggage of associated risks, personal costs, and potential costs to society? More broadly, do patients have a fundamental right to medical choice? These questions seem particularly appropriate today on
Do Patients Have a Fundamental Right to Choice? Read More »
Statins have been hailed as some of the best drugs ever. Given the massive, deadly prevalence of cardiovascular disease, some have even semi-jokingly talked about putting these drugs in the water supply for public health. The growing evidence (e.g. this story) that statins might significantly aid in prevention, delayed progression, or even post-treatment delay of
Statins dilemma: heart & cancer benefits, but diabetes risk Read More »
By David Brafman (from a stem cell clinic infomercial event). With the vast amount of information about stem cells available to the general public, many misconceptions exist regarding stem cells and their potential applications. Paul and other prominent stem cell scientists have done an excellent job of educating the public about the facts regarding stem
David Brafman: Attending Stem Cell Clinic Infomercial Read More »
Rumors have been flying for months that researchers in China and possibly elsewhere were shopping papers around at high-profile journals that reported gene editing and genetic modification of human embryos. Update: apparently this paper (HT to @JohnBorghi) was only reviewed for 2 days (see image at bottom of post), raising major concerns about the depth of
Researchers in China make genetically modified human embryos Read More »
Controversial TV physician Dr. Mehmet Oz hasn’t had a great year what with his disastrous testimony before Congress. (2020 Update; Dr. Oz recently had a good show on stem cell clinics so that’s something. I discussed issues with his staff prior to the show.) Now Dr. Oz has been slammed by a group doctors from
Doctors call for Dr. Oz to be booted from Columbia Read More »